A bridge towards new business opportunities in Korea Blog Post

Pharmaphenix –based at the Barcelona Science Park specializing in business development in emergent markets in Latin American and Korea with increasing activity in the Spanish market– has taken part one more year at BIO Korea, the largest partnering conference of the biotech, pharmaceutical and innovation sector in Asia. For three days, the pharmaceutical consultancy firm- with headquarters in Barcelona and in Seoul, South Korea– has intensified its contacts with key actors of the national bio-health sector to consolidate itself as a benchmark partner in the region. 

 

How tissue stiffness activates cancer Blog Post

Researchers at IBEC and their collaborators at the Georgia Institute of Technology  (Georgia Tech), publishing today in Nature Cell Biology, have identified the mechanism by which tissue stiffness activates a protein called YAP, a major oncogene. The new knowledge could potentially lead to new strategies to impair or even halt the growth of tumours.

 

STAT-Diagnostica closes a round of investment worth 25 million euros Blog Post

Medical diagnostics company  STAT-Diagnostica, located at the Barcelona Science Park (PCB), has closed a Series C financing round totaling 25 million Euros/28.5 million USD. The proceeds will be used to prepare for the 2017 European launch of its DiagCORE Near Patient Testing system. Led by new investor Gilde Healthcare, the financing round also drew participation from existing investors, including Kurma Partners, Ysios Capital, Idinvest Partners, Boehringer Ingelheim Venture Fund, Caixa Capital Risc and Axis.

 

Intelligent Pharma receives the TECNIO accreditation Blog Post

Yesterday, 7 April, the Government of Catalonia presented the new TECNIO accreditation in an event led by the Minister of Business and Knowledge, Jordi Baiget, that brought together nearly 300 people from the Catalan scientific and technological community at the Mediapro building. The seal identifies in a first phase 54 entities that offer the most innovative technologies to help business create products, processes or services. Intelligent Pharma, specialized in computational chemistry services for the pharmaceutical and biotechnological industry, based at the Parc Científic de Barcelona, was one of the companies honored to have received this accreditation. 

 

Identification of a new protein essential for ovule and sperm formation Blog Post

Scientists at he Institute for Research in Biomedicine (IRB Barcelona) –headed by ICREA researcher Angel R. Nebreda– discover a crucial protein for meiosis, the cell division process that gives rise to sex cells. Without the RingoA protein, both male and female mice are sterile. Published in Nature Communications, the results could pave the way for the development of male contraceptives.

 

Pharma companies innovate through talent management and tech transfer Blog Post

The fourth SciCloud (Scientific Cloud Conference) event held by Mind the Byte, in collaboration with the Barcelona Science Park (PCB) and CataloniaBio, on the 30th of March focused on the innovation models that four emblematic Catalan pharmaceutical companies (Uriach, Ferrer, Kern Pharma and Reig Jofre) use to compete on the global market and on how technology transfer is being successfully promoted through initiatives like Tech & Business Innovation (TBI) and at the Polytechnic University of Valencia. 

 

9th Awards of the UB Board of Trustees and the Bosch i Gimpera Foundation Blog Post

The Board of Trustees of the University of Barcelona and the Bosch i Gimpera Foundation, locat at PCB, announce the 9th Awards of the Board of Trustees and the Bosch i Gimpera Foundation. They announced two awards: the Antoni Caparrós Award, to the best project of transferring knowledge, and the Senén Vilaró Award, to the best innovative firm created by a UB graduate or affiliated with the UB Group. The deadline for applications is 31 May.

 

2016 season of Lessons Learned kicks off Blog Post

Biocat and the CataloniaBio business association are holding the first session in the 2016 season of Lessons Learned on 31 March at the Barcelona Science Park. Experts and professionals from the health and life sciences sector will participate in a session entitled: ‘Models organitzatius a les bio-empreses i la gestió del canvi: Quines són les claus de l’èxit?’ discussing the doubts that come up in moving forward with projects from the biotechnology and pharmaceutical arenas.